Novacyt

Novacyt Operating Expenses

The Total Operating Expenses of Novacyt (ALNOV.PA) as of Sep 17, 2026 is 46.92 M GBP. In the previous year, Total Operating Expenses was 17.61 M GBP — a change of 166.44% (higher).

Operating Expenses

46.92 MGBP

YoY

166.44%

Last updated:

Total Operating Expenses of Novacyt is 2026 46.92 M GBP. Total Operating Expenses of Novacyt was 2025 17.61 M GBP. It decreases by 166.44% higher compared to the previous year.

The Novacyt Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2017
8.64 M GBP
Jan 1, 2018
8.44 M GBP
Jan 1, 2019
8.52 M GBP
Jan 1, 2020
36.81 M GBP
Jan 1, 2021
26.96 M GBP
Jan 1, 2022
19.85 M GBP
Jan 1, 2023
17.61 M GBP
Jan 1, 2024
46.92 M GBP
The Novacyt Operating Expenses history
YEAROperating ExpensesYoY
46.92 MGBP+166.44%
17.61 MGBP-11.30%
19.85 MGBP-26.37%
26.96 MGBP-26.74%
36.81 MGBP+332.22%
8.52 MGBP+0.92%
8.44 MGBP-2.31%
8.64 MGBP+1.87%
8.48 MGBP+13.98%
7.44 MGBP+35.80%
5.48 MGBP
Access this data via the Eulerpool API

Novacyt Stock analysis

What does Novacyt do? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novacyt stock

Total Operating Expenses of Novacyt is 46.92 M GBP in 2026.

Total Operating Expenses of Novacyt changed from 17.61 M GBP to 46.92 M GBP, representing a 166.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Novacyt since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Novacyt historically and in real time.

Access this data via the Eulerpool API

Income Statement — Novacyt

All Key Metrics — Novacyt